Forte Bioscience Pop; Astrazeneca Reports; Paramount-Warner Latest
About this episode
Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Forte Bioscience (FBRX) is soaring as Argenx SE agreed to buy Forte Biosciences Inc. for about $2.2 billion in cash to expand its portfolio of immunology medicines.
- Astrazeneca (AZN) shares after it reported higher-than-expected profit, buoyed by blockbuster cancer medicines, with earnings per share rising 21% to $2.63 last quarter.
- Paramount Skydance (PSKY) shares are reacting to news that it paused its blockbuster deal for Warner Bros.
See omnystudio.com/listener for privacy information.
Get every episode summarized
Each time Stock Movers publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Stock Movers
Weekly Roundup: Skyworks Surges, Lululemon Falls, Cooper Drops
Stock Movers
Closing Bell: HPE Rallies, Dell Gains, Oracle Slips
Stock Movers
Oracle After Earnings, Microsoft Rallies, Adobe Disappoints
Stock Movers
Oracle Gains; Microsoft Plans Data Center Push; Adobe Forecast Misses Views
Stock Movers